Published in Prostate Cancer Prostatic Dis on April 26, 2011
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. J Urol (2015) 0.91
Red blood cell as a universal optoacoustic sensor for non-invasive temperature monitoring. Appl Phys Lett (2014) 0.85
Cryosurgery would be An Effective Option for Clinically Localized Prostate Cancer: A Meta-analysis and Systematic Review. Sci Rep (2016) 0.75
Imaging technique for real-time temperature monitoring during cryotherapy of lesions. J Biomed Opt (2016) 0.75
The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World J Surg Oncol (2015) 0.75
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology (1997) 13.27
Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol (2010) 8.93
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology (2000) 6.42
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol (2004) 5.09
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol (2010) 3.87
Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol (2008) 2.85
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology (1999) 2.41
The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer (2005) 1.59
The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res (2002) 1.57
Why older community-dwelling adults do not discuss urinary incontinence with their primary care physicians. J Am Geriatr Soc (2001) 1.50
Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology (2002) 1.41
Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology (2008) 1.39
Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology (2007) 1.20
Prostate cryotherapy: current status. Curr Opin Urol (2009) 1.10
Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology (2001) 1.07
Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer (1997) 1.07
Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol (1996) 0.99
Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology (2002) 0.99
Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer (2005) 0.99
Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology (2003) 0.96
Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol (1998) 0.96
Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey. J Urol (2010) 0.94
The evolution and state of modern technology for prostate cryosurgery. Urology (2002) 0.94
Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am (2010) 0.87
Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int (2000) 0.86
Prevalence of urinary incontinence in community dwelling men: a cross sectional nationwide epidemiological survey. Int Urol Nephrol (2006) 0.82
Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol (1996) 0.82
Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. Eur Urol (2002) 0.81
Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol (1997) 0.81
Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. Urology (2009) 0.79
Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol (1995) 0.79
Cryosurgical ablation of the prostate: pro. Urology (1996) 0.78
Is there a role for cryoablation of the prostate in the management of localized prostate carcinoma? Hematol Oncol Clin North Am (1996) 0.77
Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med (2007) 9.04
Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38
Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA (2001) 5.54
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol (2001) 4.73
Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol (1996) 3.16
Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol (2011) 2.69
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparison of human fibroblast cells and primary rabbit kidney cells for isolation of herpes simplex virus. J Clin Microbiol (1984) 2.22
Office-based test systems for HIV antibody. N Engl J Med (1993) 2.02
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis (2000) 1.61
Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke (2001) 1.56
Enumeration and speciation of enterococci found in marine and intertidal sediments and coastal water in southern California. J Appl Microbiol (2005) 1.50
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology (2001) 1.42
Comparison of total coliform, fecal coliform, and enterococcus bacterial indicator response for ocean recreational water quality testing. Water Res (2003) 1.38
Rapid herpes simplex virus detection in clinical samples submitted to a state virology laboratory. J Clin Microbiol (1985) 1.35
Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol (1996) 1.19
Patterns and correlates of prostate cancer treatment in older men. Am J Med (2011) 1.17
Subarachnoid haemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry (1993) 1.11
Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol (2000) 1.06
Amebiasis in northern Saskatchewan: pathological aspects. Can Med Assoc J (1968) 1.03
Enzyme replacement therapy in Fabry disease. J Inherit Metab Dis (2001) 1.02
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease. Neurology (2006) 1.00
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant (1997) 1.00
A proportional hazards model for truncated AIDS data. Biometrics (1993) 0.98
Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. AJNR Am J Neuroradiol (1999) 0.98
Hybridization and mating behavior in Aedes aegypti (Diptera: Culicidae). J Med Entomol (1979) 0.94
Targeted HIV seroprevalence among Vietnamese in southern California. Genitourin Med (1994) 0.93
The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis (2011) 0.93
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain (2006) 0.92
Monoclonal macroglobulinemia in malignant lymphoma. Ann Intern Med (1970) 0.91
Using strain typing to characterise a fluoroquinolone-resistant Neisseria gonorrhoeae transmission network in southern California. Sex Transm Infect (2008) 0.90
Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty. J Clin Microbiol (1992) 0.89
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Ann Oncol (2003) 0.88
Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res (1995) 0.88
Structural and electrical characteristics of high-κ Er2O3 and Er2TiO5 gate dielectrics for a-IGZO thin-film transistors. Nanoscale Res Lett (2013) 0.88
Experimental withdrawal of lithium in recovered manic-depressive patients: a report of five cases. Am J Psychiatry (1971) 0.88
The fate of the mentally ill physician. Am J Psychiatry (1969) 0.87
Growth studies on Mycobacterium BCG: oxygen preference. Microbios (1982) 0.85
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study. Ann Oncol (2002) 0.85
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial. Cancer J Sci Am (1999) 0.85
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413). Invest New Drugs (2000) 0.84
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Gynecol Oncol (1998) 0.83
Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial. Anticancer Drugs (2000) 0.82
Significant elimination of bismuth by haemodialysis with a new heavy-metal chelating agent. Nephrol Dial Transplant (1995) 0.82
Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry disease. J Neurochem (2001) 0.82
Cancer in families with systemic sclerosis. Am J Med Sci (1995) 0.81
Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last? J Urol (2012) 0.81
Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine. Curr Ther Res Clin Exp (1975) 0.79
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Invest New Drugs (1999) 0.79
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study. Gynecol Oncol (1999) 0.78
Effects of halogenated hydrocarbon anesthetics on responses to ligation of a coronary artery in chronically prepared rats. Anesthesiology (1983) 0.78
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. Invest New Drugs (1999) 0.78
Physical dynamics controlling variability in nearshore fecal pollution: fecal indicator bacteria as passive particles. Mar Pollut Bull (2012) 0.78
Follow-up of stereotaxic amygdalotomy for seizure and behavior disorders. Biol Psychiatry (1977) 0.77
Effect of educational program on compliance with glove use in a pediatric emergency department. Am J Dis Child (1992) 0.77
Familial associations with EEG variants in manic-depressive disease. Arch Gen Psychiatry (1975) 0.76
Integration and transcription of virus DNA in herpes simplex virus transformed cell lines. J Gen Virol (1980) 0.76
Follow-up of University of Virginia experience with the modified Lothrop procedure. Am J Rhinol (1997) 0.76
EEG and neurophysiological studies of lithium in normal volunteers. Biol Psychiatry (1972) 0.76
Herpes simplex virus necleic acid synthesis following infection of non-permissive XC cells. J Gen Virol (1978) 0.76
Virus inhibition assay for measurement of acyclovir levels in human plasma and urine. Antimicrob Agents Chemother (1981) 0.75
Isolation of Borrelia burgdorferi from ticks in southern California. West J Med (1992) 0.75
The effect of thalidomide on the developing rat foetus. Br J Exp Pathol (1967) 0.75
Predominant downgaze ophthalmoparesis in anti-Hu encephalomyelitis. J Neuroophthalmol (1996) 0.75
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481). Leuk Lymphoma (1998) 0.75
Stiripentol in acute/chronic efficacy tests in monkey model. Epilepsia (1986) 0.75
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas. Invest New Drugs (1994) 0.75
A double-blind comparative evaluation of flurothyl and ECT. Arch Gen Psychiatry (1968) 0.75
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 study. J Immunother (1997) 0.75
The history and development of the BCG. Practitioner (1983) 0.75
Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey. Prostate Cancer Prostatic Dis (2013) 0.75
Growth studies on Mycobacterium BCG: establishment of growth curves and measurement of the oxygen tension of the growth medium. Microbios (1982) 0.75
Gailor Mental Health Center Sociopathic personality. J Tenn Med Assoc (1968) 0.75
Dr. Allan A. Bailey. Can Med Assoc J (1967) 0.75
Roughness-controlled self-assembly of mannitol/LB agar microparticles by polymorphic transformation for pulmonary drug delivery. Mol Pharm (2014) 0.75
Eating fresh coffee grounds: psychoneurosis or sub-clinical pellagra. J Tenn Med Assoc (1973) 0.75
Interleukin-1 alpha administration increases oral granulocytes and epithelial cells. J Infect Dis (1994) 0.75
Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trial. Semin Oncol (1992) 0.75
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Ann Oncol (1994) 0.75
Factors controlling variability in nearshore fecal pollution: the effects of mortality. Mar Pollut Bull (2012) 0.75
Simultaneous magnetically directed drug convection and MR imaging. Nanotechnology (2009) 0.75
Passive-aggressive personality disorder: a search for a syndrome. Am J Psychiatry (1970) 0.75
Organ preservation using ultrabaric oxygen. Nature (1966) 0.75
Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas. Semin Oncol (1991) 0.75